IceCure Medical Ltd. Ordinary Shares ICCM
$1.96
-1.51%
at last close
Market Cap$6.72 million
P/E Ratio—
Div Yield—
Volume80.3K
52-Week Range
$1.95$42.00
Analyst Ratings
- Consensus
- Buy — 2 Buy · 0 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $1.75 (-10.7% downside)
Key Stats
- Today's Range
- $1.95 – $2.06
- 50-Day Range
- $1.95 – $3.88
- 52-Week Range
- $1.95 – $42.00
- Volume
- 80K shs
- Average Volume
- 143K shs
- Market Cap
- $6.72 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.58%
- Days to Cover
- 1.00
About IceCure Medical Ltd. Ordinary Shares
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Related Stocks
Compare head-to-head: ICCM vs NVDA·ICCM vs AAPL·ICCM vs GOOG·ICCM vs GOOGL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.